A clinical-morphological study on cholestatic presentation of nonalcoholic fatty liver disease

Digestive Diseases and Sciences

Volumn 50, Issue 6, 2005, Pages 1130-1135

  Sorrentino, P ^a   Tarantino, G ^a   Perrella, A ^a   Micheli, P ^b   Perrella, O ^b   Conca, P ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b D Cutugno Hospital   (Italy)

Author keywords

Cholangitis; Cholestasis; Histology; Liver; NAFLD; NASH

Indexed keywords

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILE DUCT INJURY; BODY MASS; CHOLANGITIS; CHOLESTASIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DATA BASE; DEMOGRAPHY; DISEASE ASSOCIATION; EDEMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER DYSFUNCTION; LIVER HISTOLOGY; MEDICAL RECORD; MORPHOLOGICAL TRAIT; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

AGED; CHOLESTASIS, INTRAHEPATIC; DIABETES COMPLICATIONS; DISEASE PROGRESSION; FATTY LIVER; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; OBESITY;

EID: 20844448737     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-2719-1     Document Type: Article

References (46)

1. Ludwig J, McGill DB, Lindor KD: Review: nonalcoholic steatohepatitis. J Gastroenterol Hepatol 12:398-403, 1997
2. Lee RG: Alcoholic and nonalcoholic steatohepatitis pathology. In Clinical and Pathological Correlations in Liver Disease: Approaching the Next Millennium. Bloomer JR, Goodman ZD, Ishak KG (eds). Washington, DC, Armed Forces Institute of Pathology, American Registry of Pathology, American Association for the Study of Liver Diseases, 1998, pp 274-283
3. Bacon BR, Farahvash MJ, Janney CG, Neuschwander Tetri BA: Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 107:1103-1109, 1994
4. Sheth SG, Gordon FD, Chopra S: Nonalcoholic steatohepatitis. Ann Intern Med 126:137-145, 1997
5. Tung BY, Carithers RL:. Cholestasis and alcoholic liver disease. Clin Liver Dis 3:585-601, 1999
6. Perrillo RP, Griffin R, DeSchryver-Kecskemeti K, Lander JJ, Zuckerman GR: Alcoholic liver disease presenting with marked elevation of serum alkaline phosphatase. A combined clinical and pathological study. Am J Dig Dis 23:061-1066, 1978
7. McGill DB: Steatosis, cholestasis, and alkaline phosphatase in alcoholic liver isease. Am J Dig Dis 23:1057-1060, 1978
8. Afshani P, Littenberg GD, Wollman J, Kaplowitz N: Significance of microscopic cholangitis in alcoholic liver disease. Gastroenterology 75:1045-1050, 1978
9. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR: Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94:2467-2474, 1999
10. Kumar KS, Saboorian MH, Lee WM: Cholestatic presentation of chronic hepatitis C: a clinical and histological study with a review of the literature. Dig Dis Sci 46:2066-2073, 2001
11. Giannini E, Ceppa P, Botta F, Fasoli A, Romagnoli P, Cresta E, Venturino V, Risso D, Celle G, Testa R: Steatosis and bile duct damage in chronic hepatitis C: distribution and relationships in a group of Northern Italian patients. Liver 19:432-137, 1999
12. Chia SC, Bergasa NV, Kleiner DE, Goodman Z, Hoofnagle JH, Di Bisceglie AM: Pruritus as a presenting symptom of chronic hepatitis C. Dig Dis Sci 1998; 43:2177-2183, 1998
13. Lebovics E, Seif F, Kim D, Elhosseiny A, Dworkin BM, Casellas A, Clark S, Rosenthal WS: Pruritis in chronic hepatitis C: association with high serum bile acids, advanced pathology, and bile duct abnormalities. Dig Dis Sci 42:1094-1099, 1997
14. Poonawala A, Nair SP, Thuluvath PJ: Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 32:689-692, 2000
15. World Health Organisation: Diabetes Mellitus. Report of WHO Study Group. Technical Report Series No. 727. Geneva, WHO, 1985
16. Dixon BJ, Prithi SB, O'Brien P: Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 121:91-100, 2001
17. Deugnier YM, Turlin B, Powell LW, et al.: Differentiation between heterozygotes and homozygotes in genetic hemochromatosis by means of a hystological hepatic iron index: a study of 192 cases. Hepatology 17:30-34, 1993
18. Sorrentino P, Tarantino G, Conca P, Perrella A, Terracciano ML, Vecchione R, Gargiulo G, Gennarelli N, Lobello R: Silent non-alcoholic fatty liver disease - a clinical-histological study. J Hepatol 41:751-757, 2004
19. Ishak KG, Zimmerman HJ, Ray MB: Alcoholic liver disease: pathologic, pathogenetic and clinical aspects. Alcohol Clin Exp Res 15:45-66, 1991
20. Lammert F, Matern S: Hepatic diseases caused by drugs. Schweiz Rundsch Med Prax 86:1167-1171, 1997
21. Zimmerman HJ: Hepatotoxicity. Dis Mon 39:675-787, 1993
22. Angelico M, Della Guardia P: Review article: hepatobiliary complications associated with total parenteral nutrition. Aliment Pharmacol Ther Suppl 2:54-57, 2000
23. Quigley EM, Marsh MN, Shaffer JL, Markin RS: Hepatobiliary complications of total parenteral nutrition. Gastroenterology 104:286-301, 1993
24. Fleming CR: Hepatobiliary complications in adults receiving nutrition support. Dig Dis 12:191-198, 1994
25. Craig RM, Neumann T, Jeejeebhoy KN, Yokoo H: Severe hepatocellular reaction resembling alcoholic hepatitis with cirrhosis after massive small bowel resection and prolonged total parenteral nutrition. Gastroenterology 79:131-137, 1980
26. Stanko RT, Nathan G, Mendelow H, Adibi SA: Development of hepatic cholestasis and fibrosis in patients with massive loss of intestine supported by prolonged parenteral nutrition. Gastroenterology 92:197-202, 1987
27. Duerksen DR, Van Aerde JE, Gramlich L, Meddings JB, Chan G, Thomson AB, Clandinin MT: Intravenous ursodeoxycholic acid reduces cholestasis in parenterally fed newborn piglets. Gastroenterology 111:1111-1117, 1996
28. Beau P, Labat-Labourdette J, Ingrand P, Beauchant M: Is ursodeoxycholic acid an effective therapy for total parenteral nutrition-related liver disease? J Hepatol 20:240-244, 1994
29. Spagnuolo MI, Iorio R, Vegnente A, Guarino A: Ursodeoxycholic acid for treatment of cholestasis in children on long-term total patenteral nutrition: a pilot study. Gastroenterology 111:716-719, 1996
30. Lee RG: Nonalcoholic steatohepatitis: tightening the morphological screws on a hepatic rambler. Hepatology 22:1714-1719, 1995
31. Diehl AM, Goodman Z, Ishak KG: Alcohol-like liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 95:1056-1062, 1988
32. Itoh S, Yougel T, Kawagoe K: Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis. Am J Gastroenterol 82:650-654, 1987
33. Abrams GA, Kunde SS, Lazenby AJ, Clements RH: Portal fibrosis and hepatic steatosis in morbidly obese subjects: a spectrum of non-alcoholic fatty liver disease. Hepatology 40:475-483, 2004
34. Edmondson HA, Peters RL, Frankel HH, Borowsky S: The early stage of liver injury in the alcoholic. Medicine 46:119-129, 1967
35. Ballard H, Bernstein M, Farrar JT: Fatty liver presenting as obstructive jaundice. Am J Med 30:196-201, 1961
36. Glover SC, McPhie JL, Brunt PW: Cholestasis in acute alcoholic liver disease. Lancet 2:1305-1307, 1977
37. Hall P, Smith RD, Gormely BM: "Routine" stains on osmicated resin embedded hepatic tissue. Pathology 14:73-74, 1982
38. Brunt PW, Kew MC, Sceuer PJ, Sherlock S: Studies in alcoholic liver disease in Britain. Clinical and pathological pattern related natural history. Gut 15:52-58, 1974
39. Harinasuta U, Zimmerman HJ: Alcoholic steatonecrosis. Relationship between severity of hepatic disease and presence of Mallory bodies in the liver. Gastroenterology 60:1036-1046, 1971
40. Birschbach HR, Harinasuta U, Zimmerman HJ: Alcoholic steatonecrosis. Gastroenterology 66:1195-1202, 1974
41. Poupon R, Poupon RE: Ursodeoxycholic acid therapy of chronic cholestatic conditions in adults and children. Pharmacol Ther 66:1-15, 1995
42. Ludwig J, Viggiano TR, McGill DB, Oh BJ: Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55:434-438, 1980
43. DeFronzo RA, Ferrannini E: Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14(3):173-194, 1991
44. Paradis V, Perlemuter G, Bonvoust F, Dargere D, Parfait B, Vidaud M,Conti M, Hulet S, Ba N, Neffet C, Bedossa P: High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis Hepatology 34:738-744, 2001
45. Ferrannini E: Insulin resistance, iron, and the liver. Lancet 355:2181-2182, 2000
46. George DK, Goldwurm S, MacDonald GA, Cowley LL, Walker NI, Ward PJ, Jazwinska EC, Powell LW: Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 114:311-318, 1998